CURED I - LENT Late Effects of Cancer Treatment on Normal Tissues
Philip Rubin, L.S. Constine, Lawrence B. Marks, Paul Okunieff
Springer Science & Business Media, Dec 27, 2007 - Medical - 140 pages
The rapid advances in radiation oncology, radiation biology, and radiation therapy physics have led to an accumulation of information on the interactions of radiation with other therapeutic modalities, such as the wide array of chemotherapeutic agents being employed in combination with radiation therapy, as well as the multiple biologic response modi? ers that are being used in combination with radiation therapy. It is now recognized that they have a signi? cant impact on normal tissue toxicities. The radiation doses customarily deemed safe on the basis of past experience have now, when combined with other modalities, led to severe late effects in different vital organs. The previously de? ned radiation tolerance dosages remain as valuable guides, but their applicability has changed signi? cantly. The emphasis is now placed on the volume of the organ irradiated, as well as the dose being used. New constructs rel- ing global (whole organ) and focal (partial volume) injury as a function of the dose volume histogram emerge as a signi? cant predictor of late effects on normal tissues. There are now mathematical models such as the model on standard dose, time–dose factors, and accumulated radiation effects that have been supplanted by linear-q- dratic equations using the alpha/beta ratio and its clinical applicability to normal tissue complications. This volume presents contemporary data relating to late effects on normal tissues.
What people are saying - Write a review
We haven't found any reviews in the usual places.
ACE inhibitors acute adverse effects amifostine angiogenesis angiotensin anthracyclines assessment breast cancer Cancer Center cancer patients cancer survivorship research cancer treatment captopril cardiac chemotherapy Children’s chronic Clin Oncol clinical COG LTFU Guidelines cytokines Department of Radiation diagnosis DNA damage dose dysfunction Edited effects of cancer endothelial cells endothelium evaluation exposure fatigue fibrosis follow-up function grade heart Hodgkin’s disease hypoxia imaging IMRT increased Int J Radiat interventions irradiation late effects lung base lung cancer lung injury macrophages Medicine normal tissue injury NTCP Oncol Biol Phys pediatric perfusion pneumonitis pulmonary Radiat Oncol Biol Radiat Res radiation biology radiation injury radiation nephropathy Radiation Oncology radiation pneumonitis radiation therapy radiation-induced radiologic Radiother radiotherapy regions renal Rochester Rubin screening second cancers sequelae survivors of childhood survivors treated symptom severity therapeutic thoracic tion toxicity treatment plans tumor UTCP UTCPQALY vascular volume